Bristol-Myers Squibb Announces Dividend
NEW YORK--(BUSINESS WIRE)--Sep 12, 2018--The Board of Directors of Bristol-Myers Squibb Company (NYSE:BMY) today declared a quarterly dividend of forty cents ($0.40) per share on the $.10 par value Common Stock of the corporation. The next quarterly dividend will be payable on November 1, 2018, to stockholders of record at the close of business on October 5, 2018.
The directors also declared a quarterly dividend of fifty cents ($0.50) per share on the $2.00 Convertible Preferred Stock of the corporation, payable December 3, 2018 to stockholders of record at the close of business on November 6, 2018.
About Bristol-Myers Squibb
Bristol-Myers Squibb is a global biopharmaceutical company whose mission is to discover, develop and deliver innovative medicines that help patients prevail over serious diseases. For more information about Bristol-Myers Squibb, visit us at BMS.com or follow us on LinkedIn, Twitter, YouTube and Facebook.
View source version on businesswire.com:https://www.businesswire.com/news/home/20180912005819/en/
CONTACT: Bristol-Myers Squibb
Lisa McCormick Lavery, 609-252-7602
Tim Power, 609-252-7509
Bill Szablewski, 609-252-5894
KEYWORD: UNITED STATES NORTH AMERICA NEW YORK
INDUSTRY KEYWORD: HEALTH BIOTECHNOLOGY PHARMACEUTICAL GENERAL HEALTH
SOURCE: Bristol-Myers Squibb Company
Copyright Business Wire 2018.
PUB: 09/12/2018 04:10 PM/DISC: 09/12/2018 04:10 PM